Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Application of Stem Cell Educator Therapy for the Treatment of Viral Inflammation Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

NCT04299152 is registered in ClinicalTrials.gov with Throne Biotechnologies Inc. as lead sponsor.

NCT NCT04299152
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04299152 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Application of Stem Cell Educator Therapy for the Treatment of Viral Inflammation Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Lead sponsor
Throne Biotechnologies Inc.
Phase
Phase 2
Overall status
Unknown status
Start date
November 10, 2021
Completion date
June 10, 2022
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

severe acute respiratory syndrome (sars) pneumonia